Bioline Rx's total assets for Q4 2024 were $38.91M, a decrease of -26.23% from the previous quarter. IL:BLRX total liabilities were $25.45M for the fiscal quarter, a -42.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.